Security key
48576U106
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)
CUSIP: 48576U106
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 22,658,403
- Total 13F shares
- 59,160,795
- Share change
- -3,844,560
- Total reported value
- $622,242,344
- Put/Call ratio
- 247%
- Price per share
- $10.52
- Number of holders
- 163
- Value change
- -$49,072,460
- Number of buys
- 81
- Number of sells
- 79
Report period
Q1 2021
Institutions
163
Top holders
10
KPTI full security history
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Karyopharm Therapeutics Inc. SEC filings
Karyopharm Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48576U106
Recent filing periods:
Top shareholders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
33%
|
7,475,099
|
$115,713,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
24%
|
5,339,859
|
$82,661,000 | — | 31 Dec 2020 | |
| Palo Alto Investors LP |
13F
|
Company |
23%
|
5,267,652
|
$81,543,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
15%
|
3,480,399
|
$53,877,000 | — | 31 Dec 2020 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
14%
|
3,127,571
|
$48,415,000 | — | 31 Dec 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
12%
|
2,666,416
|
$41,276,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
11%
|
2,494,901
|
$38,621,000 | — | 31 Dec 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
11%
|
2,465,000
|
$38,158,000 | — | 31 Dec 2020 | |
| Delphi Management Partners VIII, L.L.C. |
13F
|
Company |
10%
|
2,263,006
|
$35,031,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9.6%
|
2,179,215
|
$33,734,000 | — | 31 Dec 2020 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
8%
|
1,822,781
|
$28,217,000 | — | 31 Dec 2020 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
7.3%
|
1,661,236
|
$25,716,000 | — | 31 Dec 2020 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
6.9%
|
1,552,504
|
$24,033,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.4%
|
1,456,901
|
$22,553,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
6.1%
|
1,382,133
|
$21,396,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.7%
|
1,054,762
|
$16,328,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.6%
|
1,039,847
|
$16,096,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
4.5%
|
1,027,588
|
$15,907,000 | — | 31 Dec 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
4.3%
|
980,464
|
$15,178,000 | — | 31 Dec 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
4.2%
|
951,578
|
$14,731,000 | — | 31 Dec 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
4.1%
|
931,754
|
$14,424,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.4%
|
780,852
|
$12,087,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
3.3%
|
742,913
|
$11,501,000 | — | 31 Dec 2020 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.1%
|
702,351
|
$10,872,000 | — | 31 Dec 2020 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
2.6%
|
600,000
|
$9,288,000 | — | 31 Dec 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.2%
|
506,900
|
$7,847,000 | — | 31 Dec 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
2.2%
|
502,542
|
$7,779,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.1%
|
467,069
|
$7,231,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.8%
|
401,123
|
$6,209,000 | — | 31 Dec 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.7%
|
381,332
|
$5,903,000 | — | 31 Dec 2020 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.6%
|
362,505
|
$5,612,000 | — | 31 Dec 2020 | |
| AMI ASSET MANAGEMENT CORP |
13F
|
Company |
1.6%
|
357,349
|
$5,532,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
334,978
|
$5,186,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
328,960
|
$5,093,000 | — | 31 Dec 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
1.4%
|
307,103
|
$4,754,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
277,075
|
$4,289,000 | — | 31 Dec 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
1.2%
|
261,729
|
$4,052,000 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
1%
|
230,465
|
$3,569,000 | — | 31 Dec 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.96%
|
217,430
|
$3,366,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.94%
|
213,933
|
$3,312,000 | — | 31 Dec 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.83%
|
188,000
|
$2,910,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.75%
|
169,908
|
$2,631,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.74%
|
166,711
|
$2,581,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.71%
|
161,023
|
$2,493,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
0.71%
|
160,610
|
$2,486,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.69%
|
156,227
|
$2,418,000 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.65%
|
146,603
|
$2,269,000 | — | 31 Dec 2020 | |
| Phocas Financial Corp. |
13F
|
Company |
0.62%
|
140,867
|
$2,180,000 | — | 31 Dec 2020 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
135,335
|
$2,095,000 | — | 31 Dec 2020 | |
| Altium Capital Management LLC |
13F
|
Company |
0.59%
|
133,951
|
$2,074,000 | — | 31 Dec 2020 |
Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q1 2021
As of 31 Mar 2021,
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,160,795 shares.
The largest 10 holders included
BlackRock Inc., Palo Alto Investors LP, STATE STREET CORP, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, Delphi Management Partners VIII, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, RICE HALL JAMES & ASSOCIATES, LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
163
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
165
Q1 2021 holders
163
Holder diff
-2
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.